GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: AFFX
Neutral $11

Affymetrix, Inc. (NASDAQ: AFFX) downgraded to Neutral with price target $11 by Robert W. Baird

Wednesday,  Jan 21, 2015  8:25 AM ET by Lynn Gilbert

Robert W. Baird downgraded Affymetrix, Inc. (NASDAQ: AFFX) to Neutral with price target
$11. Previously, Robert W. Baird rated Affymetrix, Inc. (NASDAQ: AFFX) to Outperform with price target $11 on 06/02/2011, when the stock price was valued at $6.62.

Affymetrix scientists invented the world's first high-density microarray and began selling the first commercial microarray. Since then, Affymetrix GeneChip technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy